Mir146a Polymorphism in Gastric, Colon and Rectum Cancers
Author:
AĞBEKTAŞ Tuğba1ORCID, TAŞ Ayça2ORCID, ATABEY Mustafa3ORCID, SARI İsmail4ORCID, BOSTANCI Meriç Emre5ORCID, TOPCU Ömer1ORCID, SİLİĞ Yavuz1ORCID
Affiliation:
1. SIVAS CUMHURIYET UNIVERSITY 2. Sivas Cumhuriyet Üniversitesi-Sağlık Bilimleri Fakültesi 3. BAHCESEHIR UNIVERSITY 4. KIRKLARELI UNIVERSITY 5. Sivas Sample Hospital
Abstract
mir146a, a member of the microRNA family, plays an important role in the regulation of many biological pathways such as the regulation and differentiation of hematopoietic cells. The relationship between mir146a polymorphism and gastric, colon, rectum cancers have been investigated in Turkish population. Polymorphism in mir146a gene rs2961920 and rs2910164 have been determined in 212 patients (gastric: 73, colon:76 and rectum:63) and in 77 healthy controls by Real-Time PCR. Findings were evaluated by logistic regression and Khi (χ2) tests. The comparison of gastric, colon and rectum cancer patients and controls determined a statistically significant relationship for alcoholic drink consumption (p0.05). However, there was statistically significant relationship between this polymorphism and gastric cancer in GG+CG and CC genotypes when the gastric cancer patients and control group were evaluated for mir146a rs2910164 polymorphism (χ2: 5,49 p: 0,019). Similarly, there was statistically significant relationship between this polymorphism and gastric cancer in GG+CC and CG genotypes (χ2:5,39, p: 0,020). In this study, it is thought that by investigating the functions of microRNAs and their role in cancer, it may be promising in understanding the molecular pathology of cancer and in developing molecular targeted therapies.
Funder
Sivas Cumhuriyet Üniversitesi Bilimsel Araştırma Proje Birimi
Publisher
Cumhuriyet University
Reference29 articles.
1. Akkız, H., Sümbül, A. T., Bayram, S., Bekar, A., and Akgöllü, E. (2010). MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population. Cancer epidemiology, 34(4), 448-452. 2. Calin, G.A., and Croce, C.M. (2006). MiRNA signatures in human cancers. Nature reviews cancer, 6(11), 857-866. 3. Calin, G.A., Sevignani, C., Dumitru, C.D., Hyslop, T., Noch, E., Yendamuri, S., and 4. Croce, C. M. (2004). Human miRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proceedings of the National academy of Sciences of the United States of America, 101(9), 2999-3004. 5. Chae, Y.S., Kim, J.G., Lee, S.J., Kang, B.W., Lee, Y.J., Park, J.Y., and Choi, G.S. (2013). A mir146a polymorphism (rs2910164) predicts risk of and survival from colorectal cancer. Anticancer research, 33(8), 3233-3239.
|
|